4P-Pharma is pleased to share the second video of a series of three videos made in collaboration with Entreprendre magazine in order to highlight innovative biotechnology companies. In this second video, we spotlight our company preclinical vision. Driven by the vision of combining the biology of untreated diseases with the mechanism of action of drugs, we&hellip
4P-Pharma is pleased to share with you a series of three videos produced in collaboration with Entreprendre magazine in order to highlight innovative biotechnology companies. This series of three videos opens the doors of our company which is dedicated to the regeneration of active drugs in order to develop first class therapies to cure untreated&hellip
4Moving Biotech announces the equity investment of the Arthritis Foundation to support the clinical development of its disease-modifying osteoarthritis drug candidate
4Moving Biotech, a spin-off of 4P-Pharma focusing on the development of 4P004, a first-in-class Disease Modifying OsteoArthritis Drug (DMOAD) announces the equity investment of the Arthritis Foundation to support the clinical development of its disease-modifying osteoarthritis drug candidate. “We are very pleased with the commitment of the Foundation Arthritis. Patients have always been the core of our&hellip
4Moving Biotech, a biotechnology company and subsidiary of 4P-Pharma, focusing on the development of 4P004, a first-in-class disease modifying osteoarthritis drug (DMOAD) for a curative treatment of osteoarthritis, announces that it has enrolled its first patient for phase I of LASARE clinical trial study. “We are so excited to have the first patient enrolled in our first-in-human phase&hellip
4P-Pharma is present at BIO Europe 2022! Join us at the digital event. Roselina Lam, our Business Development and Licensing–in Manager, will attend the upcoming BIO Europe on October 24-26, 2022 in Leipzig, Germany! To learn more about us, our pipeline and discuss future partnership, please feel free to connect with us by e-mail or via the partnering platform. For further information, click here!
4P-Pharma is attending to BioJapan, as a part of french biotechnology company partner with Business France-Santé delegation, from October 12th to 14th in Yokohama, Japan. Meet our CEO, Revital Rattenbach in person during the event. Keep in touch with Roselina Lam, our Business development and Licensing-in manager to be informed about our portfolio or to discuss&hellip